93 results
Page 5 of 5
DEFA14A
e9tiy xijqshdldda5
6 Apr 20
Additional proxy soliciting materials
4:53pm
DEF 14A
0mnisz v46z35n
6 Apr 20
Definitive proxy
4:52pm
8-K
EX-99.1
gohemb3 3ypod6d7
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
8-K
w3owq7d
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
10-K
966eavupbrhw5o3r
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
5annelu
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
8-K
EX-99.1
4s3q7j59 jtxiy4
12 Feb 20
Vir Biotechnology Identifies Two Antibodies That Bind to The Spike Protein of
5:02pm
8-K
EX-99.1
785ynp efdfen
19 Nov 19
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:05pm
424B4
snuaru3u ngl8v9fu2us
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
gqsgtpj3j1r6 vp
30 Sep 19
IPO registration (amended)
6:12am
S-1
qh49ub0982io 51
3 Sep 19
IPO registration
4:40pm
DRS/A
fapo zy214
7 Aug 19
Draft registration statement (amended)
12:00am
DRS
wts4sg8nbj4068
27 Jun 19
Draft registration statement
12:00am